112 POSTER Multimodal therapy of gastrointestinal stromal tumours (GIST). A review of 24 patients

Philip P. Metzger, R Schiessel(Ludwig Boltzmann Institute for Cardiovascular Research), Barbara M. Holzer, M. Mina-Pour, Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz)

European Journal of Surgical Oncology

November 1, 2006

10.1016/s0748-7983(06)70547-9

Cited by 0

Related Papers

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

|Blood|2012|596

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

|Journal of Clinical Oncology|2011|540

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

|Blood|2011|448

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

|The Lancet Haematology|2020|351

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

|Blood Cancer Journal|2015|273